Original Article Paediatr Indones, Vol. 49, No. 6, November 2009 349 Correlation between cord blood bilirubin level and incidence of hyperbilirubinemia in term newborns Rudy Satrya, Sjarif Hidayat Effendi, Dida Akhmad Gurnida From the Department of Child Health, Medical School, Padjadjaran Universitv, Hasan Sadikin Hospital, Bandun,, lndonesia. Reprint requests to: Rudy Satrya, MD, Department of Child Health, Medical School, Padjadjaran Univeristy, Hasan Sadikin Hospital, Jl. Pasteur no. 3o, Bandun, 11O61, lndonesia. 1el/ lax. 62-22-2O35957. l-mail: rd_stry@yahoo.co.id. aundice is a clinical condition that is often present and constitutes one of the major issues during neonatal period due to transient bilirubin conjugation deficiency, including hepatic uptake and intracellular transport deficiency, and increased enterohepatic circulation. 1,2 Although jaundice affects nearlv all newborns, 5' to 6' of healthv term newborns develops si,nificant hvperbilirubinemia (> 12.9 m,/dl). 3 1his condition can cause cellular dama,e, especiallv brain neuron damage resulting in neurological problems after several years or even death. 4 American Academy of Pediatrics (AAP) reports that kernicterus has at least 1O' mortalitv and 7O' lon,-term morbiditv if total serum bilirubin (1SB) level is hi,her than 2O m,/dl. 5 Dischar,in, healthv term newborns from the hospital after delivery at increasingly earlier postnatal ages has recently become a common practice due to medical, social, and economic reasons. Association between an earlv dischar,ed newborn and the risk of readmission to the hospital has previouslv been reported, and it was most commonly caused by hyperbilirubinemia. 6 A study by Seidman et al 6 ln United States showed that O.36' Abstract Background Dischar,in, healthv term newborns from the hospital after delivery at increasingly earlier postnatal ages has recently become a common practice due to medical, social, and economic reasons, however it contributes to readmission because of jaundice. Objective 1o investi,ate the correlation between level of cord blood bilirubin and development of hyperbilirubinemia among healthv term newborns. Methods Prospective observational studv was performed on oo healthv term newborns. Cord blood was collected for the total bilirubin, conjugated bilirubin, unconjugated bilirubin level measurement and blood group test. Measurements of total bilirubin, conju,ated bilirubin, and unconju,ated bilirubin were repeated on the 5 th dav with serum samplin,, or as soon as the newborn appeared to be jaundice. Results Subjects were cate,orized into hvperbilirubinemia and non-hvperbilirubinemia newborns. 1here was a correlation between cord blood and the 5 th day bilirubin level. By ROC analvsis, cord blood bilirubin level of ~2.51 md/dl was determined to have hi,h sensitivitv (9O.5'), specificitv of o5', and accuracv of o6.1'. Conclusions 1here is a correlation between cord blood bilirubin level and hvperbilirubinemia in healthv term newborns. Cord blood bilirubin level at or ,reater than 2.51 m,/dl can predict the development of hyperbilirubinemia. [Paediatr Indones. 2009;49:349-54]. Keywords: cord blood, hyperbilirubinemia, early detection, newborn, jaundice J Rudy Satrya et al: Cord blood bilirubin level and hyperbilirubinemia 350 Paediatr Indones, Vol. 49, No. 6, November 2009 of healthv term newborns developed severe neonatal hvperbilirubinemia in the first postnatal week and had to be readmitted to the hospital. 6 1he problem is the recognition of jaundice becomes more difficult. Severe jaundice, and even kernicterus, can occur in some full-term healthv newborns with no apparent hemolvsis, jaundice in the first 21 hours, or anv causes other than breastfeeding hyperbilirubinemia. Early detection and recognition of risk factors before dischar,in, newborns from the hospital are the primary prevention of severe hyperbilirubinemia development. Some studies use the first 21 hours of newborns total serum bilirubin (1SB) as a predictor of hvperbilirubinemia development, while others try to find another methods such as transcutaneous bilirubinometry and cord blood bilirubin measurement. Venipuncture, which is performed to ,et the blood sample for 1SB examination, is an invasive procedure and has a risk of injury or infection, is not a practical procedure to be done as a routinely. Examination of newborns' cord blood bilirubin level is a non-invasive procedure and can increase early detection coverage to prevent severe hyperbilirubinemia. 7,o We investi,ated the correlation between level of cord blood bilirubin at birth and the development of hyperbilirubinemia in the first week of life amon, healthv term newborns. Methods 1his was a prospective cohort studv, carried out at Perinatology Division, Department of Child Health, Hasan Sadikin Hospital, Bandung, during the period Januarv to lebruarv 2OO9. We enrolled healthv full-term newborns (37-12 weeks of ,estation as determined bv New Ballard Score), both ,enders, delivered bv va,inal deliverv or cesarean section with birth wei,ht ~ 25OO , and Ap,ar score ~ 7 at 5 minutes. Newborns with AB incompatibilitv were excluded. All subjects were cared with the roomin,- in method to ensure the practice of exclusive breastfeedin,. lnformed consent was obtained from all parents. 1he studv was approved bv the 1he Health Research Ethics Committee, Medical School, Padjadjaran University, Bandung. Historv takin, was performed to the mother, includin, mother's a,e, ethnic, medical historv, pre,nancv historv, dru,, siblin,'s historv of jaundice, and parents' blood ,roup. Cord blood samples were collected from all newborns that complied with the inclusion criteria protocol at the delivery. An amount of 2 ml cord blood was required and sent to clinical laboratory of Hasan Sadikin Hospital for the measurement of total bilirubin, conjugated bilirubin, Figure 1. Nomogram of risk determination in well newborns at 36 or more weeks gestational age with birth weight of 2000 g or more or 35 or more weeks gestational age and birth weight of 2500 g or more based on the hour-specic serum bilirubin values Rudy Satrya et al: Cord blood bilirubin level and hyperbilirubinemia Paediatr Indones, Vol. 49, No. 6, November 2009 351 unconju,ated bilirubin level (referred as 1B O , CB O , UB O, thereafter) and blood ,roup test. 1he newborns were then followed up accordin, to the routine neonatal unit admission procedure. Measurement of total bilirubin, conjugated bilirubin, unconjugated bilirubin level were repeated on dav 5 (1B 5 , CB 5 , UB 5 ) with serum samplin,, or as soon as the newborn appeared to be jaundice. Newborns whose parents were dischar,ed earlv, were su,,ested to visit the perinatology clinic in the outpatient department on dav 5, or as soon as the newborns appeared to be jaundiced. 1otal bilirubin (1B) level was measured usin, Vitros 25O Chemistrv Svstem Spectrophotometer (rtho-Clinical Dia,nostics, Johnson c Johnson Companv) at room temperature. Subjects with 1B level of ~ 12.9 m,/dl on the 5 th dav or when the newborns appeared to be jaundice were defined as having hyperbilirubinemia and they had to undergo phototherapy. Non-phvsiolo,ic hvperbilirubinemia was defined as level of 1SB above the 95 th percentile based on the normogram (Figure 1). 9,1O Blood group incompatibility was defined as a newborn with non- blood ,roup who was delivered bv blood ,roup mother, or rhesus-positive newborns who were delivered from rhesus-ne,ative mother. 11 1he correlation between cord blood bilirubin level and 1SB on dav 5 or when the newborns appeared to be jaundice was determined bv the linear re,ression analvsis. 1he correlation stren,th of these variables was determined usin, Pearson correlation coefficient. 1he cut-off point of total cord blood bilirubin level was determined using the receiver operating characteristic (RC) curve analvsis, then sensitivitv, specificitv, and accuracv were obtained. Cord blood bilirubin level and confoundin, risk factors were analvzed with lo,istic re,ression, and P values with si,nificance of less than O.O5 were considered statisticallv si,nificant. Results A total of oo newborns was enrolled, 5O (57') were male and 3o (13') female. Mean ,estational a,e was 3o.9 weeks, and mean birth wei,ht was 3O57 ,rams. Sixtv-six newborns (75') were delivered va,inallv, the rest were delivered bv cesarean section. 1wentv-one newborns (21') developed si,nificant Table 1. Characteristics of subjects Characteristics Hyperbilirubinemia P Yes (n=21) No (n=67) Gender - n Male Female Delivery mode - n Vaginal Cesarean Subjects blood group - n A B O AB Mothers blood group - n A B O AB Feeding pattern - n Breast milk Partially breast milk Formula milk Gestational age - weeks Mean (SD) Range Birth weight - g Mean (SD) Range Maternal age - yr Mean (SD) Median Range Parity - n Mean (SD) Interval 16 5 16 5 8 4 7 2 11 5 5 0 8 13 0 38.7 (1.42) 37-42 2981(326) 2500-3600 27.76(7.6) 27.0 17-40 0.86 (1.24) 0-4 34 33 50 17 23 16 23 5 29 15 18 5 39 24 4 39 (1.30) 37-42 3080(428.3) 2500-4170 27.43(5.74) 27.0 17-39 1.01(1.39) 0-9 0.040 0.885 0.956 0.587 0.08 0.287
0.402
0.833
0.439
T test analysis
Mann-Whitney test analysis
Figure 2. ROC curve analysis Rudy Satrya et al: Cord blood bilirubin level and hyperbilirubinemia 352 Paediatr Indones, Vol. 49, No. 6, November 2009 hvperbilirubinemia (total serum bilirubin ~ 12.9 m,/ dl on dav 5). 1here was a si,nificant difference in sex between newborns who developed and did not develop si,nificant hvperbilirubinemia (P~O.O1). Characteristics of subjects are presented in Table 1. Statistical analvsis with Mann-Whitnev test showed that conju,ated and unconju,ated bilirubin level in cord blood was si,nificantlv different (P<O.OO1) between both ,roups (Table 2). Re,ression analvsis was used to determine correlation between total bilirubin in cord blood and on dav 5 with equation: v~ 6.o251.16Ox (r~O.71O, P<O.OO1). By ROC analysis (Figure 2), it was determined that total bilirubin level in cord blood of ~ 2.51 m,/ dl had a hi,h sensitivitv (9O.5'), hi,h specificitv (o5'), and accuracv of o6.1' (Table 3). Reliabilitv was determined with Kappa lndex (K) of O.66o (substantial a,reement). lo,istic re,ression analvsis was used to determine risk factors involved in the development of significant hvperbilirubinemia, and sex that in bivariables showed significant association (Table 4). Discussion 1here is a concern about increasin, incidence of kernicterus in healthy term neonates, and hyperbilirubinemia is one of the most common causes for readmission of the newborns. 1he need for earlv detection of hyperbilirubinemia in early discharged newborns from the hospital is therefore important. Knowled,e of infants at risk of developin, jaundice allows simple bilirubin reducin, methods to be implemented before bilirubin levels reach critical levels. 13 1his studv showed a si,nificant correlation between total bilirubin level in cord blood and incidence of si,nificant hvperbilirubinemia (P<O.OO1) and critical level of 2.51 m,/dl could predict the development of significant hyperbilirubinemia in the first week of life with sensitivitv of 9O.5', specificitv of o5', and accuracv of o6.1'. Bernaldo and Segre 11 found that the critical bilirubin level of ~ 2.O m,/dl indicated 53' probabilitv of the need for further treatment by phototherapy, and when the level was 3.O m,/dl, the probabilitv of needin, treatment was o6'. lf it was 3.5 m,/dl, the Table 2. Bilirubin level in subjects cord blood Bilirubin in cord blood Hyperbilirubinemia Z M-W P value Yes (n=21) No (n=67) Total bilirubin (mg/dL) Mean (SD) Median Interval Conjugated bilirubin (mg/dL) Mean (SD) Median Interval Unconjugated bilirubin (mg/dL) Mean (SD) Median Interval 3.77(1.07) 3.50 2.34-6.60 0.23(0.31) 0.0 0.0-0.86 3.53(1.20) 3.40 1.71-6.60 2.14(0.58) 2.03 0.90-4.22 0.18(0.28) 0.0 0.0-0.87 1.94(0.60) 1.90 0.80-3.93 6.084 0.659 5.564 <0.001 0.51 <0.001 SD=Standard deviation; Z M-W = Mann-Whitney test Tabel 3. Sensitivity, specicity, and accuracy of total bilirubin critical level in cord blood on development of significant hyperbilirubinemia Total Bilirubin Critical Level in Cord Blood (mg/dL) Hyperbilirubinemia Total Yes (n=21) No (n=67) 2.54 <2.54 19 2 10 57 29 59 Total 21 67 88 Tabel 4. Logistic regression analysis Variable B Coefcient SE(B) P value OR (95%CI) Cord total bilirubin (2.54 mg/dL) Gender ( to ) Constanta 4.473 -2.026 -0.824 0.925 0.826 - <0.001 0.014 - 87.60 (14.3 to 536.68) 0.132 (0.026 to 0.665) Model Accuracy: 90.9% SE: standard error Rudy Satrya et al: Cord blood bilirubin level and hyperbilirubinemia Paediatr Indones, Vol. 49, No. 6, November 2009 353 probabilitv went up to 93' (P<O.OO1). Sun et al 15 found that cord blood bilirubin level could predict the development of significant hyperbilirubinemia in healthv term newborns. 1his studv show the bilirubin in cord blood critical level of ~ 35 umol/l (2 m,/dl) had positive predictive value of 15.6o' and sensitivitv of 6o.27 (P<O.OO1). Rataj et al 16 carried out a studv in oOO healthv term newborns and the results showed a similaritv with the current studv as reported that critical bilirubin level in cord blood of >2.5 m,/dl had a probabilitv of o9' for the development of si,nificant hvperbilirubinemia in newborns. Knudsen, 17 in 19o9, carried out a studv to demonstrate that jaundiced newborns presented higher umbilical cord blood bilirubin levels than newborns without clinical jaundice. ln addition, the number of jaundiced newborns under,oin, phototherapv was si,nificantlv hi,her when these levels were hi,her than 2.3 m,/1OO dl, in comparison with number of jaundiced newborns with no need for treatment whose bilirubin levels were lower than or equal to 2.3 m,/1OO dl. 1his proved the possibilitv of definin, a newborn risk ,roup for developin, neonatal hyperbilirubinemia at birth. 1here are conflictin, reports of the predictabilitv of cord blood bilirubin of later hyperbilirubinemia. A studv in lran, concluded that cord bilirubin levels could not identifv newborn infants who were at risk for developing significant hyperbilirubinemia. 1o A total of 631 healthv term and exclusivelv breast-fed newborns were enrolled in this studv. Seventv-six newborns (11.o') had si,nificant hvperbilirubinemia (~11 m,/ dl) with mean level of bilirubin in cord blood of 37.1 (SD 17) umol/l (2.2 (SD 1.O) m,/dl) and mean level of bilirubin in cord blood was 31 (SD 16) umol/l (2.O (SD O.9) m,/dl) in newborns who did not develop significant hyperbilirubinemia. Based on the data there was no si,nificant difference between two ,roups. Critical level of bilirubin in cord blood found was 1 m,/dl with sensitivitv of 7.9', specificitv of 97.7', positive predictive value of 31.6', and ne,ative predictive valeu of oo.o'. Based on the data, it was found that bilirubin level in cord blood could not predict the development of significant hvperbilirubinemia in newborns. We found that male newborns had hi,her risk of developin, si,nificant hvperbilirubinemia (P~O.O1). AAP had reported male gender as one of the minor risk factor, 12 this was in a,reement with previous studies. 1o,19 lourteen subjects were dropped out from our follow-up and this condition could influence statistical analysis in this studv. limited period of follow up, also not dailv total and unbound bilirubin measurements were also considered as the weakness of our studv. We conclude that bilirubin level in cord blood has a correlation with the incidence of si,nificant hvperbilirubinemia in term newborns. Bilirubin level of ~2.51 m,/dl could predict the development of si,nificant hvperbilirubinemia in term newborns. References 1. Maisels MJ. Jaundice. ln: MacDonald MO, Seshia MMK, Mullett MD, editor. Averv's neonatolo,v. 6 th edition. Philadelphia: lippincott Williams c Wilkins, 2OO5, p. 76o-o16. 2. Rubaltelli l, Dani C. Neonatal jaundice. ln: Kurjak A, Chervenak lA, editor. 1extbook of perinatal medicine. 2nd edition. New York: lnforma Healthcare, 2OO6, p. 5o-6o. 3. Bhutani VK, Oourlev OR, Adler S, Kreamer B, Dalin C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischar,e newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2OOO,1O6:e17. 1. Arimbawa lM, Soetjinin,sih, Kari lK. Adverse effects of hyperbilirubinemia on the development of healthy term infants. Paediatr lndones. 2OO6,17:51-6. 5. lp S, Chun, M, Kuli, J, 'Brien R, Se,e R, Olicken S, et al. An evidence-based review of important issues concernin, neonatal hvperbilirubinemia. Pediatrics. 2OO1,111:e13O-53. 6. Seidman DS, Stevenson DK, lr,az z, Oale R. Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics. 1995,96:727-9. 7. Bernaldo AJN, Se,re CAM. Bilirubin dosa,e in cord blood: could it predict neonatal hvperbilirubinemia' Sao Paulo Med J. 2OO1,122:99-1O3. o. Martin l. Cord blood samplin,-cord blood tests |homepa,e on the internet]. c2OOo |cited 2OOo Mav 29]. Available from: www.medicineonline.com/topics/C/2/cord-blood-samplin,/ cord-blood-tests/info/html. 9. Madan A, MacMahon JR, Stevenson DK. Neonatal hvperbilirubinemia. ln: 1aeusch HW, Ballard RA, Oleason CA, editor. Averv's diseases of the newborn. o th ed. Philadelphia: WB Saunders Co, 2OO5, p. 1226-53. Rudy Satrya et al: Cord blood bilirubin level and hyperbilirubinemia 354 Paediatr Indones, Vol. 49, No. 6, November 2009 1O. Madan A, Won, RJ, Stevenson DK. Clinical features and management of unconjugated hyperbilirubinemia in term and near term infants |homepa,e on the internet]. c2OOo |cited 2OOo Mav 29]. Available from: https://store.utdol.com/app/ index.asp. uptodate. 11. Nicolaides KH, Sebire NJ. Mana,ement of the red cell isoimmunized pre,nancies. ln: Kurjak A, Chervenak lA, editor. 1extbook of perinatal medicine. 2nd edition. New York: lnforma Healthcare, 2OO6, p. 1151-61. 12. American Academv of Pediatrics Subcommittee on Hyperbilirubinemia: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of ,estation. Pediatrics. 2OO1,111:297-316. 13. Rostami N, Mehrabi Y. ldentifvin, the newborns at risk for developing significant hyperbilirubinemia by measuring cord bilirubin levels. J Arab Neonatal lorum. 2OO5,2:o1-5. 11. Sun O, Wan, Yl, lian, Jl, Du lz. Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice. zhon,hua lr Ke za zhi. 2OO7,15:o1o-52. 15. Rataj J, Kornacka M, Korman l. Usefulness of measurin, bilirubin level in cord blood for predicting hyperbilirubinemia in newborns. Oinekol Pol. 1991,65:276-oO. 16. Knudsen A. Prediction of the development of neonatal jaundice by increased umbilical cord blood bilirubin. Acta Paediatr. 19o9,7o:217-21. 17. Rostami N, Mehrabi Y. ldentifvin, the newborns at risk for developing significant hyperbilirubinemia by measuring cord bilirubin levels. J Arab Neonatal lorum. 2OO5,2:o1-5. 1o. Newman 1B, Xion, B, Oonzales VM, lscobar OJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2OOO,151:111O-7. 19. Maisels MJ, Krin, lA. len,th of stav, jaundice and hospital readmission. Pediatrics 199o,1O1:995-o.